Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · PITTSFIELD, MA · NPI 1235394495
Verified facts
CMS Open Payments records show Arun Bansal, MD received $121.98 in general payments during 2025 across 1 reported records.
UCB, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| UCB, Inc. | Unresolved — no canonical attribution shown | $121.98 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $121.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Rystiggo Normalized: rystiggo |
Drug | UCB, Inc. | $121.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 518 | 153 |
| Levothyroxine Sodium | Levothyroxine Sodium | 372 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 361 | 103 |
| Lisinopril | Lisinopril | 324 | 98 |
| Metoprolol Succinate | Metoprolol Succinate | 308 | 92 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 301 | 94 |
| Losartan Potassium | Losartan Potassium | 276 | 75 |
| Gabapentin | Gabapentin | 226 | 59 |
| Omeprazole | Omeprazole | 226 | 66 |
| Fluticasone Propionate | Fluticasone Propionate | 223 | 90 |
| Famotidine | Famotidine | 207 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 182 | 62 |
| Eliquis | Apixaban | 169 | 36 |
| Simvastatin | Simvastatin | 153 | 42 |
| Furosemide | Furosemide | 140 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 138 | 40 |
| Metformin Hcl | Metformin Hcl | 133 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 132 | 51 |
| Tramadol Hcl | Tramadol Hcl | 131 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 113 | 38 |
| Allopurinol | Allopurinol | 111 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 26 |
| Mirtazapine | Mirtazapine | 96 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 90 | 21 |
| Jardiance | Empagliflozin | 89 | 18 |
| Metformin Hcl Er | Metformin Hcl | 75 | 23 |
| Lorazepam | Lorazepam | 71 | 22 |
| Montelukast Sodium | Montelukast Sodium | 69 | 26 |
| Alprazolam | Alprazolam | 68 | 17 |
| Trazodone Hcl | Trazodone Hcl | 66 | 15 |
| Glipizide Er | Glipizide | 65 | 23 |
| Sertraline Hcl | Sertraline Hcl | 63 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 60 | 20 |
| Ozempic | Semaglutide | 56 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 55 | 15 |
| Potassium Chloride | Potassium Chloride | 54 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 51 | 12 |
| Prednisone | Prednisone | 48 | 36 |
| Clonazepam | Clonazepam | 47 | suppressed |
| Bupropion Xl | Bupropion Hcl | 46 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 45 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 44 | 12 |
| Celecoxib | Celecoxib | 43 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 43 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 42 | suppressed |
| Diazepam | Diazepam | 40 | suppressed |
| Glimepiride | Glimepiride | 40 | 11 |
| Methylprednisolone | Methylprednisolone | 40 | 36 |
| Spironolactone | Spironolactone | 40 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 40 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 35 |
| Azithromycin | Azithromycin | 37 | 34 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 37 | 11 |
| Topiramate | Topiramate | 37 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 36 | 11 |
| Pregabalin | Pregabalin | 36 | suppressed |
| Xarelto | Rivaroxaban | 36 | 12 |
| Atenolol | Atenolol | 35 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 32 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 32 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 31 | 31 |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 15 |
| Ezetimibe | Ezetimibe | 30 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | 11 |
| Lamotrigine | Lamotrigine | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Carvedilol | Carvedilol | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | 15 |
| Dilantin | Phenytoin Sodium Extended | 26 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Ibuprofen | Ibuprofen | 23 | 12 |
| Irbesartan | Irbesartan | 23 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | 11 |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 11 |
| Finasteride | Finasteride | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 12 |
| Naproxen | Naproxen | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Pentips Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $121.98 · 1 records | UCB, Inc. | Rystiggo | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error